Onward

Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.

Lara Smith Weber

CFO

1 past transactions

NeuroRecovery Technologies

Acquisition in 2019
NeuroRecovery Technologies, a medical device company based in San Juan Capistrano, California, specializes in developing innovative therapeutic systems aimed at restoring function and enabling movement for individuals suffering from paralysis. Founded in 2013, the company emerged from collaborative research efforts involving prominent institutions such as the University of California Los Angeles, the California Institute of Technology, and the University of Louisville. Its product offerings include both external and implantable spinal cord neuromodulation systems, which are designed to enhance recovery and rehabilitation for patients with spinal cord injuries. NeuroRecovery Technologies has positioned itself at the forefront of advancements in the field, providing physicians with tools to improve care for their patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.